Therapeutic milestones against multidrug resistant Acinetobacter baumannii: from legacy antibiotics to Zosurabalpin

Puntos clave

• Therapeutic intervention against multidrug resistant Acinetobacter baumannii shows significant promise with Zosurabalpin.
• Research indicates that traditional antibiotics are becoming less effective, necessitating new drug discovery.
• Analysis incorporates legacy antibiotics and their mechanisms alongside novel compounds like Zosurabalpin.
• Finding effective treatments is critical, as multidrug resistance poses a significant public health concern.